133 related articles for article (PubMed ID: 35670970)
21. Tumor margin histology predicts tumor aggressiveness in papillary thyroid carcinoma: a study of 514 consecutive patients.
Kim KJ; Hong SW; Lee YS; Kim BW; Lee SC; Chang HS; Park CS
J Korean Med Sci; 2011 Mar; 26(3):346-51. PubMed ID: 21394301
[TBL] [Abstract][Full Text] [Related]
22. Macroscopic Examination of Surgical Specimen of Papillary Thyroid Carcinoma.
Lam AK
Methods Mol Biol; 2022; 2534():79-91. PubMed ID: 35670969
[TBL] [Abstract][Full Text] [Related]
23. Comparative pathological characteristics of papillary thyroid carcinoma with second primary non-thyroid malignancies in the region affected by the Chernobyl accident.
Fridman M; Krasko O; Levin L; Veyalkin I; Lam AK
Pathol Res Pract; 2021 Dec; 228():153658. PubMed ID: 34749211
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.
Huang Y; Yin Y; Zhou W
Front Endocrinol (Lausanne); 2021; 12():640565. PubMed ID: 33746905
[TBL] [Abstract][Full Text] [Related]
27. Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.
Baser H; Ozdemir D; Cuhaci N; Aydin C; Ersoy R; Kilicarslan A; Cakir B
Endocr Pathol; 2015 Dec; 26(4):356-64. PubMed ID: 26481630
[TBL] [Abstract][Full Text] [Related]
28. Preoperative and Postoperative Risk Stratification of Thyroid Papillary Microcarcinoma: A Comparative Study Between Kuma Criteria and 2015 American Thyroid Association Guidelines Risk Stratification.
Pérez-Soto RH; Velázquez-Fernández D; Arellano-Gutiérrez G; Chapa-Ibargüengoitia M; Trolle-Silva AM; Iñiguez-Ariza N; Pérez-Enríquez B; Sierra-Salazar M; Pantoja Millán JP; Herrera MF
Thyroid; 2020 Jun; 30(6):857-862. PubMed ID: 32031061
[No Abstract] [Full Text] [Related]
29. Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants.
Ho AS; Luu M; Shafqat I; Mallen-St Clair J; Chen MM; Chen Y; Jain M; Ali N; Patio C; Filarski CF; Lin DC; Bankston H; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2021 Oct; 31(10):1549-1557. PubMed ID: 34470466
[No Abstract] [Full Text] [Related]
30. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
Forleo R; Grani G; Alfò M; Zilioli V; Giubbini R; Zatelli MC; Gagliardi I; Piovesan A; Ragni A; Morelli S; Puxeddu E; Pagano L; Deandrea M; Ceresini G; Torlontano M; Puligheddu B; Antonelli A; Centanni M; Fugazzola L; Spiazzi G; Monti S; Rossetto R; Monzani F; Tallini G; Crescenzi A; Sparano C; Bruno R; Repaci A; Tumino D; Pezzullo L; Lombardi CP; Ferraro Petrillo U; Filetti S; Durante C; Castagna MG
Thyroid; 2021 Dec; 31(12):1814-1821. PubMed ID: 34541894
[No Abstract] [Full Text] [Related]
31. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
32. Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancer.
Lu Y; Moreira AL; Hatzoglou V; Stambuk HE; Gonen M; Mazaheri Y; Deasy JO; Shaha AR; Tuttle RM; Shukla-Dave A
Thyroid; 2015 Jun; 25(6):672-80. PubMed ID: 25809949
[TBL] [Abstract][Full Text] [Related]
33. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
34. Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients.
Haglund F; Garvin S; Ihre-Lundgren C; Nilsson IL; Hall E; Carling T; Höög A; Juhlin CC
Endocr Pathol; 2016 Dec; 27(4):346-351. PubMed ID: 27251056
[TBL] [Abstract][Full Text] [Related]
35. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
36. The Role of SPECT/CT Lymphoscintigraphy and Radioguided Sentinel Lymph Node Biopsy in Managing Papillary Thyroid Cancer.
Cabrera RN; Chone CT; Zantut-Wittmann DE; Matos PS; Ferreira DM; Pereira PS; Ribeiro MP; Santos AO; Ramos CD; Crespo AN; Etchebehere EC
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):834-41. PubMed ID: 27366869
[TBL] [Abstract][Full Text] [Related]
37. Axillary lymph nodes metastasis in a patient with recurrent papillary thyroid cancer: a case report.
Hafez MT; Refky B; Elwahab KA; Arafa M; Abdou I; Elnahas W
J Med Case Rep; 2015 Aug; 9():181. PubMed ID: 26307101
[TBL] [Abstract][Full Text] [Related]
38. Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.
Thomas A; Mittal N; Rane SU; Bal M; Patil A; Ankathi SK; Vaish R
Head Neck Pathol; 2021 Dec; 15(4):1137-1146. PubMed ID: 33840044
[TBL] [Abstract][Full Text] [Related]
39. The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes.
Rowe ME; Ozbek U; Machado RA; Yue LE; Hernandez-Prera JC; Valentino A; Qazi M; Brandwein-Weber M; Liu X; Wenig BM; Urken ML
Endocr Pathol; 2018 Mar; 29(1):80-85. PubMed ID: 29396810
[TBL] [Abstract][Full Text] [Related]
40. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
